Sort
15,842 grants matching “pancreatic cancer”
Dim light at night alters pancreatic cell signaling and predisposes to pancreatic adenocarcinoma
$167,475Souhad Chbeir · Ohio State University · R21 · FY2017 · CA
Development of New Therapeutics for Pancreatic Cancer Management
$167,475Richard Joseph Pietras · University Of California Los Angeles · R21 · FY2013 · CA
Identifying new drug targets to block K-Ras/Raf in pancreatic cancer.
$167,475Philip J.s. Stork · Oregon Health & Science University · R21 · FY2016 · CA
n-3 Fatty Acid &Host Responses to Oral Infection
$167,474University Of Kentucky · R21 · FY2002 · DE
Core D: Administrative Core
$167,454Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
AP 4. Drug Screening and Pharmacology
$167,400Eric W Schmidt · University Of Utah · U19 · FY2016 · TW
Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis
$167,400Gregory B Carey · University Of Maryland Baltimore · K22 · FY2008 · CA
Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis
$167,400Gregory B Carey · University Of Maryland Baltimore · K22 · FY2007 · CA
Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis
$167,400Gregory B Carey · University Of Maryland Baltimore · K22 · FY2009 · CA
SToP Cancer SPORE: Administrative Core A
$167,361Jen Jen Yeh · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA
Core B-Modeling & Experimental Therapeutics Core
$167,327James Wesley Horner · University Of Tx Md Anderson Can Ctr · P01 · FY2025 · CA
MR-Guided Precision Thermal Therapy of Retroperitoneal Tumors
$167,297Frank Graham Sommer · Stanford University · P01 · FY2014 · CA
TARGETED DELIVERY OF GENES TO ANGIOGENIC VASCULATURE
$167,205University Of Texas Md Anderson Can Ctr · R01 · FY2001 · CA
A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer
$167,198Mark W Jackson · Case Western Reserve University · R21 · FY2014 · CA
B7-H3 CAR T cell-based immunotherapy combined with Losartan to counteract desmoplasia for the treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
$167,163Soldano Ferrone · Massachusetts General Hospital · R03 · FY2021 · CA
MUC1-Targeted Nanotherapy for Pancreatic Cancer
$167,112Jordan M Winter · Thomas Jefferson University · R21 · FY2014 · CA
Training the Next Generation of Surgeon-Scientists in Pancreatology
$167,093Masato Yamamoto · University Of Minnesota · T32 · FY2018 · DK
P53 and KRAS Targeted Pigs: A Platform for Models of Human Cancer
$167,065Christopher Rogers · Exemplar Genetics, Llc · R43 · FY2012 · CA
Targeting Smad3-Ski for Therapeutic Development in Pancreatic Cancer
$167,063F. Michael Hoffmann · University Of Wisconsin-Madison · R21 · FY2008 · CA
Project 4: Model-Based Dosimetry and Imaging for PDT
$167,050Brian William Pogue · Massachusetts General Hospital · P01 · FY2017 · CA
Development of a protein drug for pancreatic cancer treatment
$167,021Zhi-Ren Liu · Proda Biotech, Llc · R41 · FY2017 · CA
Implementing Prevention of Venous Thromboembolism for Ambulatory Patients with Cancer (PREVenT-APC)
$167,003Karlyn Martin · Northwestern University At Chicago · K23 · FY2022 · HL
Implementing Prevention of Venous Thromboembolism for Ambulatory Patients with Cancer (PREVenT-APC)
$166,998Karlyn Martin · Northwestern University At Chicago · K23 · FY2023 · HL
Core D: Administrative Core
$166,987Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2019 · CA
Structural and functional investigation of the understudied HIPK1 kinase
$166,955Natalia Jura · University Of California, San Francisco · R03 · FY2020 · TR